1 year return (CAGR)
-13.12%
Arbonia AG Exchange (SW, CHF)
ARBN.SW
4.54
+0.04 (+0.78%)
IndustrialsBuilding Products & Equipment
Loading...
3 year return (CAGR)
-17.44%
5 year return (CAGR)
-24.00%
10 year return (CAGR)
-11.30%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
315.06M
Price/Sales
0.26
Ent value
683.32M
Price/Book
0.44
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-255.97%
Trailing P/E
3.47
PEG
-
Forward P/E
29.31
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 4.60 |
| Daily high | 4.63 |
| Daily low | 4.54 |
| Daily Volume | 28K |
| All-time high | 92.34 |
| 1y analyst estimate | 5.80 |
| Beta | 0.76 |
| EPS (TTM) | 1.31 |
| Dividend per share | 0.00 |
| Ex-div date | 29 Apr 2025 |
| Next earnings date | 3 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ARBN.SW | S&P500 | |
| Current price drop from All-time high | -95.09% | -0.13% |
| Highest price drop | -96.19% | -56.47% |
| Date of highest drop | 8 Jul 2026 | 9 Mar 2009 |
| Avg drop from high | -65.76% | -10.66% |
| Avg time to new high | 111 days | 12 days |
| Max time to new high | 4871 days | 1805 days |
News
Studsvik has signed a frame agreement with Norwegian Nuclear Decommissioning (NND), the Norwegian state agency responsible for decommissioning the country's nuclear facilities, to manage spent nuclear...
October 16, 2026
Hera has delivered a solid 53.6% share price gain over the past three years, which naturally puts fresh attention on whether that move is backed up by its earnings power today. With the stock last clo...
October 16, 2026
Fresh CPI data shows US inflation at 3.7% in September, with AI data center construction flagged as one of the cost drivers. Rising prices and the prospect of higher rates are pressuring many growth s...
October 14, 2026
PARIS, October 14, 2026--Regulatory News: Gecina (Paris:GFC):
October 14, 2026
BOSTON, October 14, 2026--MindWalk Holdings Corp. (NASDAQ: HYFT) ("MindWalk" or the "Company"), a Bio-Native AI company, today announced three senior appointments that strengthen its Boston-based deve...
October 14, 2026
Novartis (SWX:NOVN) received FDA approval for Rhapsido (remibrutinib) as a treatment for chronic spontaneous urticaria and symptomatic dermographism when antihistamines are insufficient. Rhapsido beco...
October 14, 2026
China’s latest trade report has lit a fire under global commodity stories, with September exports up 36.3% and imports up 31% year on year. That kind of two way traffic can reshape demand for everythi...
October 14, 2026
Johnson & Johnson says it is working to improve results in its medical-device business, where surgery revenue fell for the latest quarter.
October 13, 2026
BOSTON, October 13, 2026--SOUFFLÉ THERAPEUTICS, INC. ("Soufflé™" or "Company"), a leading RNA therapies company aimed at advancing the next generation of therapies designed to help people live healthi...
October 13, 2026
Phanes Therapeutics, Inc. (Phanes), a clinical-stage biotech company focused on innovative drug discovery and development in immuno-oncology (IO), announced that Ming Wang (CEO) will participate in Bo...
October 13, 2026